Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | GRM7 | Q14831 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9946454 | 0.94 | ALDH1A1 (0.42) | ALDH1A1MAPTHPGDKDM4EGAA | |
| SCHEMBL9946477 | 0.90 | GRM7 (0.40) | ALDH1A1MAPTHPGDKDM4EGAA | |
| SCHEMBL18724356 | 0.90 | ALDH1A1 (0.41) | ALDH1A1MAPTHPGDKDM4EGAA | |
| SCHEMBL1275123 | 0.90 | ALDH1A1 (0.44) | ALDH1A1MAPTHPGDKDM4EGAA | |
| SCHEMBL17399561 | 0.89 | ALDH1A1 (0.46) | ALDH1A1MAPTHPGDKDM4EGAA | |
| SCHEMBL9944023 | 0.89 | ALDH1A1 (0.52) | ALDH1A1MAPTHPGDKDM4EGAA | |
| SCHEMBL1275752 | 0.87 | ALDH1A1 (0.44) | ALDH1A1MAPTHPGDKDM4EGAA | |
| SCHEMBL1275881 | 0.87 | ALDH1A1 (0.42) | ALDH1A1MAPTHPGDKDM4EGAA | |
| SCHEMBL1274974 | 0.87 | ALDH1A1 (0.42) | ALDH1A1MAPTHPGDKDM4EGAA | |
| SCHEMBL1275839 | 0.85 | ALDH1A1 (0.45) | ALDH1A1MAPTHPGDKDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9227923-B2 | Pesticidal carboxamides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-01-05 | — | — | US | disclosed |
| EP-2464624-A2 | PESTICIDAL CARBOXAMIDES | Bayer CropScience AG (DE) | 2012-06-20 | — | — | EP | disclosed |
| US-20120149910-A1 | Pesticidal Carboxamides | BAYER CROPSCIENCE AG (DE) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149910-A1 | Pesticidal Carboxamides | DDT, ACHE, AADAC | ALDH1A1 1360/4885MAPT 4596/4885HPGD 2719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.